DAVIS, CA – September 19, 2017 – Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), based in Davis, California, is a leading provider of bio-based pest management and plant health products for agriculture, turf, ornamental and water treatment markets.

ÉLÉPHANT VERT, a Swiss group that strives for healthy and sustainable agriculture, with the support of the Antenna Foundation, has 300 employees in five countries in Africa and Europe and develops and markets organic amendments, biofertilizers, biostimulants and 100% natural biopesticides made in four production units.

Together, these two pioneering players of the biological crop protection market have the products and knowledge to bring sustainable solutions for improving both yield and quality to farmers in North Africa.

ÉLÉPHANT VERT will develop and market two of MBI’s products in Morocco, Tunisia and Algeria:

  • The biofungicide REYSANA™ is currently labeled for use by growers of tomatoes, peppers, grapes and cucurbits. Reysana contains the same ingredients as MBI’s Regalia Maxx Biofungicide, which is already marketed and sold in more than 10 countries worldwide.
  • The bionematicide MAJESTENE, which protects crops from yield-robbing nematodes. The product is inside the registration process.

Vincent Thieyre, Products & Solutions Development Director of ÉLÉPHANT VERT, said: “Integrating biopesticides into crop protection programs benefits all production, and is increasingly important for exporters of vegetables in the region. Growers of key crops in Morocco are eagerly awaiting Reysana’s official launch event in Agadir on September 21st 2017, followed by a similar event in Tunisia. These events are significant milestones that solidify the cooperation between our two companies.”

Dr. Pamela Marrone, CEO and Founder of MBI said: “We are delighted by this partnership that is part of our international development strategy; this agreement enables MBI to expand to new markets in North Africa while meeting farmers’ needs with innovation-driven biological products.”

Sébastien Couasnet, CEO of ÉLÉPHANT VERT, added, “This agreement opens up new promising development opportunities to provide North-African farmers with a wider range of natural, efficient and innovative solutions.”

ELEPHANT VERT is an international business-oriented group, acting with the financial support from Antenna Foundation, a specialized foundation in research, adaptation and transfer of innovative technologies to fight against poverty and promote sustainable development. Our ambition: develop and promote a sustainable agricultural model. ÉLÉPHANT VERT offers innovative and sustainable agricultural products and services. One of our key differentiators are microorganisms with agricultural purpose that have a positive impact throughout theagricultural cycle by helping to restore soil biodiversity and fertility and improve plant growth and resistance to diseases and pests.

ÉLÉPHANT VERT develops a global approach “from lab bench to farmers’ field” providing farmers with an effective and 100% natural crop protection. ÉLÉPHANT VERT offers also technical, financial and industrial support services. Established in Morocco, Mali, Senegal and France, ÉLÉPHANT VERT Group has developed a referent offer in Africa as well as in Europe, and participates daily in the advent of an efficient healthy and sustainable agriculture. Visit our website: www.elephant-vert.com
ÉLÉPHANT VERT Press Contact:
Communication ÉLÉPHANT VERT
Telephone: +33 (0)7 85 87 15 15
Email: presse@elephantvert.ch

About Marrone Bio Innovations, Inc.
Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. MBI’s effective and environmentally responsible pest management solutions help customers operate more sustainably while uniquely improving plant health and increasing crop yields. MBI currently has six commercially available products (Regalia®, Grandevo®, Venerate®, Majestene®, Haven™ and Zequanox®) as well as eight product candidates in various stages of the company’s rapid development pipeline. MBI also distributes Bio-tam 2.0® for Isagro USA in the western U.S. and Jet-Ag® for Jet Harvest in most regions of the U.S.

Marrone Bio Innovations is dedicated to pioneering smart biopesticide solutions that support a better tomorrow for both farmers and consumers around the globe. For more information, please visit www.marronebio.com.

Marrone Bio Innovations Contact:
Julie Versman, Senior Director of International Business
Telephone: +1 (530) 750-2800
Email: Info@marronebio.com
MBI Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449

Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include statements regarding sales of the Company’s products, the potential benefits of the Company’s products, and MBI’s efforts with respect to expansion of its product labels in international markets. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the Company’s products, any difficulty in marketing MBI’s products in global markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers, and adverse decisions by regulatory agencies and other relevant third parties. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.